Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...
TipRanks on MSN5d
Insulet initiated with an Outperform at BernsteinBernstein initiated coverage of Insulet (PODD) with an Outperform rating and $300 price target Innovation is driving accelerated insulin pump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback